目录号: A10177
Capecitabine 是一种前体药物,它在肿瘤中通过酶的作用转化为5-氟尿嘧啶,从而抑制 DNA 合成并减缓肿瘤组织的生长。Capecitabine 的激活遵循一个包含三个酶促步骤和两个中间代谢物,5'-脱氧-5-氟胞苷(5'-DFCR)和5'-脱氧-5-氟尿苷(5'-DFUR),最终形成5-氟尿嘧啶的路径。
顾客使用 Adooq 产品发表的高质量科研文献
Adooq用户使用Capecitabine (Xeloda)发表的4篇文献
生物活性
Discription | Capecitabine is a prodrug, that is enzymatically converted to 5-fluorouracil in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. The activation of capecitabine follows a pathway with three enzymatic steps and two intermediary metabolites, 5'-deoxy-5-fluorocytidine (5'-DFCR) and 5'-deoxy-5-fluorouridine (5'-DFUR), to form 5-fluorouracil. |
|||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
产品信息
目录号 | A10177 |
---|---|
分子式 | C15H22FN3O6 |
分子量 | 359.4 |
CAS号 | 154361-50-9 |
SMILES | CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O |
其他名称 | Captabin |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
溶解性数据
In vitro | DMSO | 62 mg/mL (172.53 mM) | |
Water | 5 mg/mL (13.91 mM) | ||
Ethanol | 62 mg/mL (172.53 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Preparing Stock Solutions
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 27.82 mL | 139.12 mL | 278.24 mL |
0.5 mM | 5.56 mL | 27.82 mL | 55.65 mL |
1 mM | 2.78 mL | 13.91 mL | 27.82 mL |
5 mM | 0.56 mL | 2.78 mL | 5.56 mL |
Useful Calculator
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
Keywords: 购买 Capecitabine (Xeloda) | Capecitabine (Xeloda) 供应商 | Capecitabine (Xeloda) 花费 | Capecitabine (Xeloda) 生产商 | 订购 Capecitabine (Xeloda) | Capecitabine (Xeloda) 代理商
| 购买 154361-50-9 | 154361-50-9 供应商 | 154361-50-9 花费 | 154361-50-9 生产商 | 订购 154361-50-9 | 154361-50-9 代理商